Search

everythinglearnresearchcommunity

for

Search:↓

Beau's lines on nails may indicate severe COVID-19 or vaccination response.

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

Alopecia areata after COVID-19 vaccination is rare but important to recognize for timely treatment.

In 2021, JAMA Dermatology published significant findings on skin conditions post-COVID vaccination, melanoma surveillance, atopic dermatitis treatments, and confirmed that sun protection does not harm bone health.

COVID-19 can cause long-term health issues in many body systems, and vaccination is important to prevent these effects.

About 61% of women who had COVID-19 experienced hair loss afterward.

COVID-19 vaccines can cause mild to moderate skin reactions, mostly after the first dose.

Standardized definitions and better methods are needed to accurately estimate long COVID-19 prevalence.

Most children with MIS-C showed significant improvement by 6 months.

Long COVID is complex, affects many survivors, and needs more research for effective treatments.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

70.7% of patients had long-COVID symptoms like fatigue, cough, and brain fog three months after recovery.

COVID-19 vaccines are safe and highly effective for children, with inactivated vaccines being slightly better.

COVID-19 vaccines have been linked to an increase in hair loss conditions.

Long COVID affects about 27% of patients, with higher risk for women, lower education, and certain income levels.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Older people with severe COVID-19, especially those with certain health conditions, are more likely to experience post-COVID syndrome.

Long COVID causes lasting symptoms and needs vaccines for prevention and a team approach for treatment.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Long COVID affects many body systems and needs careful management.

COVID-19 can cause long-term skin problems and has changed how skin doctors work.

More skin issues appeared in the emergency department during COVID-19, highlighting the need for better dermatology training and resources.

People in high-income countries are more likely to accept COVID-19 booster doses than those in middle or low-income countries.

The treatment might help COVID-19 related hair loss, but more research is needed.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

Vitamin D3 deficiency can worsen psoriasis by promoting Candida overgrowth.

Many hospitalized COVID-19 patients still have symptoms like fatigue and hair loss up to a year later, especially older, lower-income individuals with other health issues.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.